Terns Pharmaceuticals Shares Surge 87% On Positive ASH Data Selection

(RTTNews) - Terns Pharmaceuticals, Inc. (TERN) shares soared 87.11 percent to $15.45, gaining $7.19 in Monday trading after announcing that data from its ongoing CARDINAL trial of TERN-701 in previously treated chronic myeloid leukemia patients has been selected for an oral presentation at the upcoming 67th American Society of Hematology Annual Meeting in Orlando.

The stock opened at $14.05 and traded between $12.77 and $16.27, compared with a previous close of $8.26 on the Nasdaq. Trading volume reached 28.4 million shares, far above the average of 1.3 million. Terns shares have traded between $1.87 and $16.27 over the past 52 weeks.